155 related articles for article (PubMed ID: 38004765)
1. A Simple In Vitro Test to Select Stools for Fecal Microbiota Transplantation to Limit Intestinal Carriage of Extensively Drug-Resistant Bacteria.
Salandre A; Delannoy J; Goudiaby MTB; Barbut F; Thomas M; Waligora-Dupriet AJ; Kapel N
Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004765
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond
Yoon YK; Suh JW; Kang EJ; Kim JY
Ann Med; 2019; 51(7-8):379-389. PubMed ID: 31468999
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Fecal Microbiota Transplantation for Clearance of Multidrug-Resistant Organisms under Multiple Comorbidities: A Prospective Comparative Trial.
Shin J; Lee JH; Park SH; Cha B; Kwon KS; Kim H; Shin YW
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289668
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review.
Macareño-Castro J; Solano-Salazar A; Dong LT; Mohiuddin M; Espinoza JL
J Infect; 2022 Jun; 84(6):749-759. PubMed ID: 35461908
[TBL] [Abstract][Full Text] [Related]
5. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review.
Manges AR; Steiner TS; Wright AJ
Infect Dis (Lond); 2016 Aug; 48(8):587-92. PubMed ID: 27194400
[TBL] [Abstract][Full Text] [Related]
7. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
Caballero S; Carter R; Ke X; Sušac B; Leiner IM; Kim GJ; Miller L; Ling L; Manova K; Pamer EG
PLoS Pathog; 2015 Sep; 11(9):e1005132. PubMed ID: 26334306
[TBL] [Abstract][Full Text] [Related]
8. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
[TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
Bilinski J; Grzesiowski P; Sorensen N; Madry K; Muszynski J; Robak K; Wroblewska M; Dzieciatkowski T; Dulny G; Dwilewicz-Trojaczek J; Wiktor-Jedrzejczak W; Basak GW
Clin Infect Dis; 2017 Aug; 65(3):364-370. PubMed ID: 28369341
[TBL] [Abstract][Full Text] [Related]
10. Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective.
Bar-Yoseph H; Carasso S; Shklar S; Korytny A; Even Dar R; Daoud H; Nassar R; Maharshak N; Hussein K; Geffen Y; Chowers Y; Geva-Zatorsky N; Paul M
Clin Infect Dis; 2021 Jul; 73(1):e166-e175. PubMed ID: 32511695
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.
Innes AJ; Mullish BH; Ghani R; Szydlo RM; Apperley JF; Olavarria E; Palanicawandar R; Kanfer EJ; Milojkovic D; McDonald JAK; Brannigan ET; Thursz MR; Williams HRT; Davies FJ; Marchesi JR; Pavlů J
Front Cell Infect Microbiol; 2021; 11():684659. PubMed ID: 34513724
[TBL] [Abstract][Full Text] [Related]
12. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms.
Hyun J; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Kim MH; Sohn Y; Cho Y; Baek YJ; Kim JH; Ahn JY; Jeong SJ; Yeom JS; Choi JY
Antimicrob Resist Infect Control; 2022 Jan; 11(1):20. PubMed ID: 35093183
[TBL] [Abstract][Full Text] [Related]
13. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review.
Saha S; Tariq R; Tosh PK; Pardi DS; Khanna S
Clin Microbiol Infect; 2019 Aug; 25(8):958-963. PubMed ID: 30986562
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
[No Abstract] [Full Text] [Related]
15. Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis.
Tavoukjian V
J Hosp Infect; 2019 Jun; 102(2):174-188. PubMed ID: 30926290
[TBL] [Abstract][Full Text] [Related]
16. High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation.
Chuang C; Lee KC; Wang YP; Lee PC; Chang TE; Huang YH; Lin YT; Hou MC
Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1103-1113. PubMed ID: 37474764
[TBL] [Abstract][Full Text] [Related]
17. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.
Li N; Zuo B; Huang S; Zeng B; Han D; Li T; Liu T; Wu Z; Wei H; Zhao J; Wang J
Microbiome; 2020 Nov; 8(1):161. PubMed ID: 33208178
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant
Liu Q; Zuo T; Lu W; Yeoh YK; Su Q; Xu Z; Tang W; Yang K; Zhang F; Lau LHS; Lui RNS; Chin ML; Wong R; Cheung CP; Zhu W; Chan PKS; Chan FKL; Lui GC; Ng SC
mSystems; 2022 Jun; 7(3):e0151021. PubMed ID: 35642928
[TBL] [Abstract][Full Text] [Related]
19. Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.
Bajaj JS; Shamsaddini A; Acharya C; Fagan A; Sikaroodi M; Gavis E; McGeorge S; Khoruts A; Fuchs M; Sterling RK; Lee H; Gillevet PM
Gut Microbes; 2021; 13(1):1993584. PubMed ID: 34743650
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
